Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
the current study hypothesized that Gabapentin can be effective as Bisoprolol in reduction of intraoperative bleeding, improving the operative's field visibility and increase the surgeon satisfaction via optimization of blood pressure and heart rate .
A prospective randomized double blinded controlled study. Eligible patients were randomized according to random list generated software and allocated into 3 equal and matched groups (15 patients in each group):-
Hypothesis:
Gabapentin can be effective as Bisoprolol in reduction of intraoperative bleeding, improving the operative's field visibility and increase the surgeon satisfaction via optimization of blood pressure and heart rate.
Objectives Compare the effect of preoperative Gabapentin with Bisoprolol on hemodynamics, surgical field optimization during endoscopic nasal surgeries.
Technical design:
A) Site of study :
The study was conducted at Anesthesia and Surgical intensive care and Otorhinolaryngology departments, faculty of medicine, Zagazig University.
B) Sample Size :
According to 80% power of the study, 95% CI and calculated volume of blood loss 200±40 ml and 150±55ml on Gabapentin (22) and Bisoprolol (15) premedication respectively, the estimated Sample size was 54 patients (open EPI) , 63 patients were included in the study to compensate for drop out.
Randomization was carried out on 63 patients to compensate for drop out . All planned ESS procedures was managed by the same anesthetist and surgeon who were blinded to the used study's premedication. The surgeon was blinded to the monitor recording the hemodynamic variables.
All patients had been preoperatively evaluated according to standard local protocol. Preoperative surgical preparation and proper management of infection were confirmed to every patient.
Patient was premedicated by IV ranitidine 50 mg, midazolam 0.05 mg/kg and atropine 20µg/kg immediately before admission to the operating room.
On admission to the operating room, Standard monitoring included 5 leads ECG, non-invasive blood pressure, Pulse Oximetry and End-tidal carbon dioxide (ETCO2) trace were applied (B40i Monitor - GE Healthcare, Finland).
Anesthesia was induced with IV propofol 2 mg/kg and fentanyl 1 µg/kg was given for analgesia. Cisatracurium 0.15 mg/kg IV was given to facilitate direct laryngoscopy and orotracheal intubation. The patient was ventilated at tidal volume 6-8mL/kg and respiratory rate that achieved ETCO2 of 30-35 mmHg. Oropharyngeal pack was inserted.
Anesthesia was maintained by isoflurane based on MAC 1.2 % until a steady state of anesthesia was achieved (defined as a state of anesthesia when no changes in hemodynamic variables take place for at least 10 min). An increase of ≥ 20% of basal value in both HR and MAP was treated with increasing the concentration of isoflurane by 0.5% and increments of fentanyl 1 μg/kg. Muscle relaxation was confirmed by cisatracurium 0.03mg/kg every 20 mins. IV lactated ringer solution was infused at approximately 6ml/kg/hr till the end of the procedure.
All patients were positioned supine and the bed-head of the surgical table was raised by 30° to improve venous drainage.
Before the beginning of surgical procedure, well wrung out cotton pledgets soaked with 4 ml of 2% lignocaine with 1:200,000 adrenaline were topically applied to the nasal mucous membrane for 10 min (no infiltration).
Technique for hemodynamic optimization:
Target mean arterial pressure (MAP) was 60-70 mmHg during the surgical procedure to achieve Fromm and Boezaart category scale of 2 or 3 which is judged to be optimal for surgery (20).
If the MAP was still ˃70mmHg in spite of increasing isoflurane inhalation to 2.5%, nitroglycerine (1-10 μg/kg/min.) titrated to effect.
If the heart rate was more than 100 beats/ minute, propranolol was titrated 1-3 mg/hour to achieve target MAP.
If mean arterial pressure (MAP) decreased to less than 60 mm Hg, ephedrine in increments of 3 mg was given.
Withdrawal vasoactive agents:
After recording the surgeons' opinion regarding the surgical field and about 15 minutes before ending surgery, the infusion of any vasoactive medication (if used) was stopped and the anesthetic agent was decreased allowing HR and MAP to return to their basal value. If Hypotension (defined as SAP< 90mmHg and bradycardia less than 60 bpm) persisted, they was treated by ephedrine in increments of 3 mg .
On compilation of surgical procedure, anesthesia was discontinued and reversal of neuromuscular blockade was achieved using IV neostigmine 0.08 mg/kg and atropine 20µg/kg. After removal of oropharyngeal pack, oropharyngeal suction was performed. On the start of obeying commands, patients were extubated and shifted to recovery room.
Patients were discharged to the ward after reaching a score ≥ 9 on the Modified Aldrete Scoring System.
During postoperative period up to 6 hours, the patient was monitored for conscious level, oxygen saturation, heart rate and mean arterial blood pressure.
On ward admission, IM diclofenac sodium 75mg was given then every 12 hours. If the patient complained moderate to severe pain (VAS≥ 4) meperidine 25mg increments up to pain relief (maximum 100mg as a single dose) was given.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| gabapentin | Active Comparator | gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative |
|
| bisoprolol | Active Comparator | bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative |
|
| control | Placebo Comparator | placebo was given to patients of control group 2 hours preoperative |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Gabapentin1200 mg | Drug | patients received 1200mg gabapentin 2 hrs preoperative |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Surgical Field Visibility | according to change in Fromm and Boezaart surgical field category scale ranging from 0 (no bleeding) to 5 (severe bleeding) where: 0 No Bleeding.
| scale was assessed by the surgeon every 15 minutes from the start of surgical procedure till the end |
| Blood Loss | total intraoperative blood loss (mL) | at the end of surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Heart Rate Change | effect of intervention on the change of heart rate allover study period | were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery |
| Mean Arterial Blood Pressure Change |
| Measure | Description | Time Frame |
|---|---|---|
| Surgeon Satisfaction (Categorical) | surgeon satisfaction score where given 5 for very satisfied, 4 for satisfied, 3 for neutral, 2 for dissatisfied and 1 for very dissatisfied then number of satisfied (satisfaction score = 5) and disatisfied (satisfaction score less than 5) surgeons was compared between groups | at the end of surgery |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Abeer M. Elnakera, doctorate | faculty of medicine - Zagazig university | Principal Investigator |
| Ayman A. Hassan, doctorate | Zagazig University | Study Chair |
| Maram wagdy, Master | Zagazig University | Study Chair |
| Mohamed W. El-Anwar, doctorate | Zagazig University | Study Chair |
Not provided
collective data sheet was available to all researchers during and after completing the study. individual patient records are available on request for all researchers
Not provided
Not provided
Not provided
Not provided
Not provided
66 patients who underwent endoscopic sinus surgery were eligible for the study
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Gabapentin Group (Group G) | 21 patients completed the study and were considered for statistical analysis |
| FG001 | Bisoprolol Group (Group B) | 22 patients were allocated to group B, completed the study and were considered for statistical analysis |
| FG002 | Control Group (Group C) | 17 patients completed the study and were considered for statistical analysis |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
63 patients were enrolled in the study. after 3 patients' withdrawal, 60 patients completed the study and considered for statistical analysis
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Gabapentin | gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative |
| BG001 | Bisoprolol | bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Changes in Surgical Field Visibility | according to change in Fromm and Boezaart surgical field category scale ranging from 0 (no bleeding) to 5 (severe bleeding) where: 0 No Bleeding.
| Posted | Median | Full Range | score on a scale | scale was assessed by the surgeon every 15 minutes from the start of surgical procedure till the end |
|
intra-operative and up to 6 hours postoperative
hypertension:MAP elevation by more than 20% from baseline value hypotension : systolic arterial pressure (SAP) less than 90 mmHg tachycardia : HR more than 90 beats/min bradycardia: HR less than 60 beats/min incidence of nausea and vomiting
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Gabapentin | gabapentin 1200 mg was given to patients of gabapentin group 2 hours preoperative |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| hypotension | Cardiac disorders | Non-systematic Assessment | SAP less than 90 mmHg |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| hypertension | Cardiac disorders | Non-systematic Assessment | MAP elevation by more than 20% from baseline |
small sample size, short study period (until 6 hrs. postoperatively) and unavailability of BIS index monitoring.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| assistant professor Abeer M. Elnakera | faculty of medicine- Zagazig university | 00201005720754 | nakera35@hotmail.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| SAP | No | Yes | No | Statistical Analysis Plan | Dec 15, 2016 | May 22, 2019 | SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D017298 | Bisoprolol |
| D014815 | Vitamins |
| ID | Term |
|---|---|
| D050198 | Phenoxypropanolamines |
| D011412 | Propanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| bisoprolol 2.5mg | Drug | patients received 2.5mg bisoprolol 2 hrs preoperative |
|
|
| placebo | Drug | patients received oral placebo 2 hrs preoperative |
|
|
effect of intervention on the change of mean arterial blood pressure allover study period |
| were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery |
| Number of Patients Who Recieved Intraoperative IV Nitroglycerin During Operative Procedure |
need for additional intraoperative IV vasodilators (nitroglycerine |
| at the end of surgery |
| Number of Patients Who Recieved Intraoperative IV Propranolol During Operative Procedure | the need for additional beta blockers (propranolol) | at the end of surgery |
| Number of Patients Who Recieve Both IV Nitroglycerin and Propranolol During Operative Procedure | need for both IV nitroglycerine and propranolol intraoperatively | at the end of surgery |
| Visual Analogue Scale (VAS) for Postoperative Pain | postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain which was assessed | 1, 3 and 6 hrs. after recovery |
| Visual Analogue Scale (VAS) for Postoperative Pain | postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain | 0n full recovery, 3 and 6 hrs. after recovery |
| Time to 1st Postoperative Rescue Analgesia | time to 1st postoperative rescue analgesia (starting from administration of the studied drug) | on administration of 1st postoperative rescue analgesia |
| BG002 | Control | placebo was given to patients of control group 2 hours preoperative |
| BG003 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| weight, continuous | patients' withdrawal from the study | Mean | Standard Deviation | kilograms |
|
| indication for surgery, categorical) | indication for surgery is either due to polyp or sinusitis | 3 patients were withdrawn from the study | Count of Participants | Participants |
|
| mean arterial blood pressure (MAP), continuous | 3 patients were withdrawn from the study | Mean | Standard Deviation | mmHg |
|
| heart rate (HR), continuous | 3 patients were withdrawn from the study | Mean | Standard Deviation | beats/minute |
|
| side of surgery | side of surgery is either bilateral or unilateral | 3 patients were withdrawn from the study | Count of Participants | Participants |
|
| OG001 | Bisoprolol | bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative |
| OG002 | Control | placebo was given to patients of control group 2 hours preoperative |
|
|
| Primary | Blood Loss | total intraoperative blood loss (mL) | Posted | Median | Full Range | mL | at the end of surgery |
|
|
|
| Secondary | Heart Rate Change | effect of intervention on the change of heart rate allover study period | Posted | Mean | Standard Deviation | beats/ minute | were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery |
|
|
|
| Secondary | Mean Arterial Blood Pressure Change | effect of intervention on the change of mean arterial blood pressure allover study period | Posted | Mean | Standard Deviation | mm Hg | were recorded before oral premedication (baseline), pre-induction, after induction of anesthesia, 1, 5, 10, 15 minutes after intubation and then every 15 minutes until the end of surgery |
|
|
|
| Other Pre-specified | Surgeon Satisfaction (Categorical) | surgeon satisfaction score where given 5 for very satisfied, 4 for satisfied, 3 for neutral, 2 for dissatisfied and 1 for very dissatisfied then number of satisfied (satisfaction score = 5) and disatisfied (satisfaction score less than 5) surgeons was compared between groups | Posted | Count of Participants | Participants | at the end of surgery |
|
|
|
| Other Pre-specified | Number of Patients Who Recieved Intraoperative IV Nitroglycerin During Operative Procedure | need for additional intraoperative IV vasodilators (nitroglycerine | Posted | Count of Participants | Participants | at the end of surgery |
|
|
|
| Other Pre-specified | Number of Patients Who Recieved Intraoperative IV Propranolol During Operative Procedure | the need for additional beta blockers (propranolol) | Posted | Count of Participants | Participants | at the end of surgery |
|
|
|
| Other Pre-specified | Number of Patients Who Recieve Both IV Nitroglycerin and Propranolol During Operative Procedure | need for both IV nitroglycerine and propranolol intraoperatively | Posted | Count of Participants | Participants | at the end of surgery |
|
|
|
| Other Pre-specified | Visual Analogue Scale (VAS) for Postoperative Pain | postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain which was assessed | Not Posted | 1, 3 and 6 hrs. after recovery | Participants |
| Other Pre-specified | Visual Analogue Scale (VAS) for Postoperative Pain | postoperative visual analogue score (VAS) for pain where 0 is no pain and 10 severe intolerable pain | Posted | Median | Full Range | score on a scale | 0n full recovery, 3 and 6 hrs. after recovery |
|
|
|
| Other Pre-specified | Time to 1st Postoperative Rescue Analgesia | time to 1st postoperative rescue analgesia (starting from administration of the studied drug) | Posted | Median | Full Range | minutes | on administration of 1st postoperative rescue analgesia |
|
|
|
| 0 |
| 21 |
| 0 |
| 21 |
| 0 |
| 21 |
| EG001 | Bisoprolol | bisoprolol 2.5 mg was given to patients of bisoprolol group 2 hours preoperative | 0 | 22 | 5 | 22 | 3 | 22 |
| EG002 | Control | placebo was given to patients of control group 2 hours preoperative | 0 | 17 | 11 | 17 | 10 | 17 |
| bradycardia | Cardiac disorders | Non-systematic Assessment | HR less than 60 beats/min |
|
|
| tachycardia | Cardiac disorders | Non-systematic Assessment | HR more than 90 beats/min |
|
| postoperative nausea | Gastrointestinal disorders | Non-systematic Assessment |
|
| postoperative vomiting | Gastrointestinal disorders | Non-systematic Assessment |
|
| agitation on recovery | Nervous system disorders | Non-systematic Assessment | Richmond Agitation Sedation Scale (RASS) equal +2 |
|
Not provided
Not provided
| D009930 |
| Organic Chemicals |
| D020005 | Propanols |
| D000588 | Amines |
| D018977 | Micronutrients |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D000078622 | Nutrients |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D019602 | Food and Beverages |
| Male |
|
| sinusitis |
|
| unilateral |
|
|
| 1 minute after intubation |
|
| 5 minutes after intubation |
|
| 10 minutes after intubation |
|
| 15 minutes after intubation |
|
| 30 minutes after intubation |
|
| 45 minutes after intubation |
|
| 60 minutes after intubation |
|
| 75 minutes after intubation |
|
| 90 minutes after intubation |
|
| 105 minutes after intubation |
|
|
| 1 minute after intubation |
|
| 5 minutes after intubation |
|
| 10 minutes after intubation |
|
| 15 minutes after intubation |
|
| 30 minutes after intubation |
|
| 45 minutes after intubation |
|
| 60 minutes after intubation |
|
| 75 minutes after intubation |
|
| 90 minutes after intubation |
|
| 105 minutes after intubation |
|
|
|
| 6hrs after recovery |
|